Shares of Kenvue Inc. KVUE slipped 4.53% to $19.80 Thursday, on what proved to be an all-around mixed trading session for the ...

Despite the large debt balance compared with its current level of cash, we expect healthy cash generation from Kenvue to meet all of its near-term financial obligations. Only $1.5 billion of debt is ...

The company has expanded adjusted gross margins by 200 basis points year-over-year to 60.4%, aided by productivity enhancements and cost-saving initiatives. Additionally, Kenvue is on track to achieve ...

Hello, and welcome to the Kenvue fourth-quarter and full-year 2024 earnings conference call. [Operator instructions] As a ...

The S&P 500 Index ($SPX) (SPY) today is up +0.29%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.12%, and the Nasdaq ...

Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and ...

For the quarter ended December 2024, Kenvue (KVUE) reported revenue of $3.66 billion, down 0.1% over the same period last year. EPS came in at $0.26, compared to $0.31 in the year-ago quarter. The ...

Kenvue (KVUE) came out with quarterly earnings of $0.26 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.31 per share a year ago. These figures are adjusted for ...

Pure-play consumer health company Kenvue Inc. (KVUE) , while reporting weak fourth-quarter profit, in line with market, on Thursday ...

The Skillman, N.J. company expects sales to rise up to 1% or fall up to 1% in 2025, based on a 2% to 4% rise in organic sales offset by a 3% headwind from unfavorable foreign exchange rates. A 1% lift ...

Kenvue Inc. (KVUE) reported a profit for fourth quarter that decreased from last year in line with the Street estimates. The ...

Consumer health company Kenvue forecast 2025 adjusted profit below Wall Street estimates on Thursday, hit by a stronger ...